Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Email today from Matt P.

<< Previous

Bullboard Posts

Next >>

Comment by TimboBagginson Dec 12, 2024 11:10am

74 Views

Post# 36358937

RE:RE:Email today from Matt P.

Kingpin68 wrote: Thanks for sharing Donein25.
Clearly, when forced to selectively pick a narrow band of patients, the potential for better CR numbers increases.
This makes Theralases data that much more impressive.

So if CGs CR is 75% of only 25% of the population then their actual CR is more like 19% of our treatable patients then?

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season